ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic – Genetic Engineering & Biotechnology News

Continue reading

2017-08-10 Michael Zand NEWS

Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic – Genetic Engineering & Biotechnology News

Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic
Genetic Engineering & Biotechnology News
Cancer Research UK and Biotecnol said they will advance an immuno-oncology treatment for lung cancers and other solid tumors into early phase clinical trials, through a collaboration whose value was not disclosed. Cancer Research UK will support early …

Continue reading

2017-08-10 Michael Zand NEWS

Treating CINV Due to Immunotherapy and Targeted Therapy – OncLive

Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy Into the Clinic
Genetic Engineering & Biotechnology News
Cancer Research UK and Biotecnol said they will advance an immuno-oncology treatment for lung cancers and other solid tumors into early phase clinical trials, through a collaboration whose value was not disclosed. Cancer Research UK will support early …

Continue reading

2017-08-09 Michael Zand NEWS

Novel Immunotherapy Combinations for NSCLC – OncLive


OncLive

Treating CINV Due to Immunotherapy and Targeted Therapy
OncLive
Lee S. Schwartzberg, MD: Beth, you mentioned immunotherapy and chemotherapy, together, for non–small cell lung cancer. This is an exciting area. We’re at the 2017 ASCO Annual Meeting, and we’re going to hear a lot about immunotherapy. What’s your …

Continue reading

2017-08-09 Michael Zand NEWS

Rare leukemia targeted by modifying patients’ immune cells – Litchfield County Times


OncLive

Novel Immunotherapy Combinations for NSCLC
OncLive
Vassiliki A. Papadimitrakopoulou, MD: ECHO-202 is a combination therapy of epacadostat and pembrolizumab in patients that are immunotherapy naïve with non–small cell lung cancer. Very early results are encouraging. We’re seeing response rates in the …

and more »

Continue reading

2017-08-09 Michael Zand NEWS

Stem Cell Implant Is Being Trialled To “Cure” Type 1 Diabetes – IFLScience


Litchfield County Times

Rare leukemia targeted by modifying patients’ immune cells
Litchfield County Times
Turning the T cells into CAR–T cells helps by targeting the CD19 marker on the B cells. “CD19 happens to be a pretty good target for cancer technology because it’s only on B cells,” Gore said. “These new CAR–T cells latch onto the leukemia cells.”.

Continue reading

2017-08-09 Michael Zand NEWS

Immunotherapy Shown Safe in Type 1 Diabetes Clinical Trial – WebMD


IFLScience

Stem Cell Implant Is Being Trialled To “Cure” Type 1 Diabetes
IFLScience
A groundbreaking attempt to “cure” Type 1 diabetes with stem cells began last week. Embryonic stem cell implants were given to two people, one in the US and one in Canada, with high-risk Type 1 diabetes. The researchers hope that this will help the …
This Scientific Breakthrough Could Be the Next Miracle Cure for Type 1 DiabetesReader’s Digest
We’re One Step Closer to Curing Type 1 Diabetes With This First-Ever Stem Cell ImplantGears Of Biz
Diabetes Cure 2017: Scientists May Have Found Treatment for Type-1 ConditionChristian Post

all 16 news articles »

Continue reading

2017-08-09 Michael Zand NEWS

Editas Medicine Announces Second Quarter 2017 Results and Update – Nasdaq

NasdaqEditas Medicine Announces Second Quarter 2017 Results and UpdateNasdaqStrengthened unmatched intellectual property position with issuance of first patent for CRISPR/Cpf1. In May, the European Patent Office issued the first patent for CRISPR/Cpf1,… Continue reading

2017-08-09 Michael Zand NEWS
  • 1
  • …
  • 1,375
  • 1,376
  • 1,377
  • 1,378
  • 1,379
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Los Angeles Times

Immunotherapy Shown Safe in Type 1 Diabetes Clinical Trial
WebMD
The immunotherapy also showed signs of helping to keep insulin production steady in people newly diagnosed with the disease, the study authors said. However, because this was a placebo-controlled safety trial, there weren’t enough people included to …
Immunotherapy succeeds in thwarting Type-1 diabetes in studyLos Angeles Times
Immunotherapy for Type 1 Diabetes Safe, Promising in Small StudyMedscape
Immunotherapy found safe for type 1 diabetes in landmark trialMedical News Today
FierceBiotech –The Scientist –Yahoo Style UK
all 111 news articles »